{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:49:39Z","timestamp":1791852579801,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtos.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:32:32Z","timestamp":1783035152000},"page":"85-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A post-HSCT ocular surface \u201cWindow of Opportunity for Pre-emptive ocular treatment (WinOP)\u201d shows early inflammatory activation and an oGVHD-like molecular subset"],"prefix":"10.1016","volume":"42","author":[{"given":"Zeenal","family":"Dabre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Geun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Ascencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Shehadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejas","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monazzah","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"504.e1","DOI":"10.1016\/j.jtct.2020.12.027","article-title":"Epidemiology and treatment of chronic graft-versus-host disease post-allogeneic hematopoietic cell transplantation: a US claims analysis","volume":"27","author":"Bachier","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtos.2026.07.002_bib3","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood.2023022735","article-title":"Chronic graft-versus-host disease: unresolved complication or ancient history?","volume":"144","author":"Pidala","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtos.2026.07.002_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2026.07.002_bib6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib7","doi-asserted-by":"crossref","first-page":"S570","DOI":"10.1016\/j.jtct.2024.06.031","article-title":"Understanding ocular graft-versus-host disease to facilitate an integrated multidisciplinary approach","volume":"30","author":"Surico","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib8","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.jtct.2025.05.016","article-title":"NIH chronic graft-versus-host disease consensus conference 2025 update","volume":"31","author":"Lee","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/biom14010102","article-title":"Molecular biomarkers in ocular Graft-versus-Host disease: a systematic review","volume":"14","author":"Bohlen","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtos.2026.07.002_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-Host disease: iia. The 2020 clinical implementation and early diagnosis working group report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib11","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2026.07.002_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.46989\/001c.124551","article-title":"Pulmonary GvHD: is it time to change the NIH diagnostic criteria?","volume":"6","author":"Canichella","year":"2024","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.jtos.2026.07.002_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jtos.2025.04.006","article-title":"Ocular graft-versus-host disease: experience, incidence, and treatment outcomes at a university-based tertiary care ophthalmology center","volume":"37","author":"Dabre","year":"2025","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.07.002_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jtos.2021.12.009","article-title":"A single institute validation study comparing the international chronic ocular graft-versus-host disease consensus group diagnostic criteria with clinical parameters","volume":"24","author":"Hiratsuka","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.07.002_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/ICL.0000000000001081","article-title":"\u201cWindow of Opportunity\u201d in ocular graft-versus-host disease treatment: results of a longitudinal study and case reports","volume":"50","author":"Surenkhuu","year":"2024","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2026.07.002_bib16","doi-asserted-by":"crossref","first-page":"226.e1","DOI":"10.1016\/j.jtct.2025.02.004","article-title":"Longitudinal tear cytokine biomarkers: an analysis from the close assessment and testing for chronic graft-versus-host disease (CATCH) protocol","volume":"31","author":"El","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib17","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41409-021-01254-5","article-title":"Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study","volume":"56","author":"Pietraszkiewicz","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtos.2026.07.002_bib18","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.3390\/ijms26094311","article-title":"Novel tear biomarkers in ocular graft versus host disease associated with Th1\/Th2 immune responses: a case series and literature review","volume":"26","author":"Timofte-Zorila","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2026.07.002_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2026.07.002_bib21","first-page":"221","volume":"vol. 21","author":"Lemp","year":"1995"},{"key":"10.1016\/j.jtos.2026.07.002_bib22","first-page":"1","article-title":"Corneal fluorescein staining in FDA-reviewed dry eye registrational clinical trials: evidence of limited endpoint responsiveness","author":"Dabre","year":"2026","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2026.07.002_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2021.11.002","article-title":"Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops (\u201cTriple play\u201d) in Recalcitrant immunological ocular surface diseases","volume":"23","author":"Katz","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.07.002_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtos.2019.10.004","article-title":"Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease","volume":"18","author":"Kwon","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.07.002_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jtos.2019.03.010","article-title":"Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: implications for novel biomarkers and therapeutic strategies","volume":"17","author":"An","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2026.07.002_bib26","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtos.2026.07.002_bib27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtos.2026.07.002_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD","volume":"31","author":"Dietrich-Ntoukas","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2026.07.002_bib19","doi-asserted-by":"crossref","first-page":"749.e1","DOI":"10.1016\/j.jtct.2022.07.023","article-title":"Biomarkers in ocular graft-versus-host disease: implications for the involvement of B cells","volume":"28","author":"Shen","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtos.2026.07.002_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/09273948.2022.2046794","article-title":"Tear film immunological profile in patients with ocular graft versus host disease","volume":"31","author":"Serapicos","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2026.07.002_bib30","first-page":"1","article-title":"Platelet-derived growth factor (PDGF) isoform imbalance is associated with innate inflammation and corneal epitheliopathy in dry eye disease","author":"Dabre","year":"2026","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jtos.2026.07.002_bib31","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.3390\/jcm13164728","article-title":"Frequency of topical immunomodulatory and immunosuppressive therapies for ocular chronic graft-versus-host disease","volume":"13","author":"Koca","year":"2024","journal-title":"J Clin Med"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012426001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012426001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:17:46Z","timestamp":1791850666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012426001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S1542012426001023"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2026.07.002","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A post-HSCT ocular surface \u201cWindow of Opportunity for Pre-emptive ocular treatment (WinOP)\u201d shows early inflammatory activation and an oGVHD-like molecular subset","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}